Determination of Cefaclor in Human Plasma by Reversed-Phase High-Performance Liquid Chromatography with UV Detection and Its Application to the Bioequivalence Studies

REFERENCES

• Chen , X. Y. , D. F. Zhong , B. Huang , and J. Cui . 2003 . Determination of cefaclor in human plasma by a sensitive and specific liquid chromatographic–tandem mass spectrometric method . J. Chromatogr. B Analyt. Technol. Biomed. Life. Sci. 784 : 17 – 24 .
   PubMed Web of Science ®Google Scholar
• Cole , P. ed. 1998 . Current Issues in the Management of Respiratory Tract Infections: A Focus on Cefaclor . London : The Royal Society of Medicine Press Ltd.
   Google Scholar
• Foglesong , M. A. , J. W. Lamb , and J. V. Dietz . 1978. Stability and blood level determinations of cefaclor, a new oral cephalosporin antibiotic. Antimicrob. Agents. Chemother. 13: 49–52.
   PubMed Web of Science ®Google Scholar
• Gupta , S. , and B. B. Prasad . 2000 . Determination of cefaclor by selective sample enrichment/clean-up on silica gel bonded polyelectrolyte in ion-exchange column chromatography . J Pharm Biomed Anal. 23 : 307 – 13 .
   PubMed Web of Science ®Google Scholar
• Kai , M. , H. Kinoshita , K. Ohta , S. Hara , M. K. Lee , and J. Lu . 2003 . Sensitive determination of a β-lactam antibiotic, cefaclor by liquid chromatography with chemiluminescence detection . J. Pharm. Biomed. Anal. 30 : 1765 – 1771 .
   PubMed Web of Science ®Google Scholar
• Kovach , P. M. , R. J. Lantz , and G. Brier . 1991 . High-performance liquid chromatographic determination of loracarbef, a potential metabolite, cefaclor and cephalexin in human plasma, serum and urine . J. Chromatogr. B. 567 : 129 – 39 .
   Web of Science ®Google Scholar
• Lü , Y. , Z. S. Kang , M. N. Wei , M. N. Li , Y. Liu , T. Y. Li , and Y. H. Xiao . 2005 . Pharmacokinetics and bioequivalence study of susta ined-release tablets and conventiona capsules of cefaclor in healthy volunteers . Chin. J. Antibiotics. 30 : 538 – 541 .
   Google Scholar
• Meyers , B. R. 2000 . Cefaclor revisited . Clin. Ther. 22 : 154 – 164 .
   PubMed Web of Science ®Google Scholar
• Nix , D. E. , W. T. Symonds , J. M. Hyatt , M. A. Teal , P. Reidenberg , and M. B. Affrime . 1997 . Comparative pharmacokinetics of oral ceftibuten, cefixime, cefaclor, and cefuroxime axetil in healthy volunteers . Pharmacotherapy 17 : 121 – 125 .
   PubMed Web of Science ®Google Scholar
• Sourgens , H. , H. Derendorf , and H. Schifferer . 1997 . Pharmacokinetic profile of cefaclor . Int. J. Clin. Pharmacol. Ther. 35 : 374 – 80 .
   PubMed Web of Science ®Google Scholar
• Tutunji , M. , O. Jarrar , M. Musameh , S. M. Alam , and D. R. Quamruzaman . 2001 . Bioequivalence evaluation of two brands of cefaclor 500 mg capsules: Quantification of cefaclor using solid phase extraction technique . J. Clin. Pharm. Ther. 26 : 149 – 153 .
   PubMed Web of Science ®Google Scholar
• U. S. Department of Health and Human Services. Food and Drug Administration Centre for Drug Evaluation and Research (2001). Guidance for Industry–Bioanalytical Method Validation .
   Google Scholar